Active — Not RecruitingNot Applicable

Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants

Italy60 participantsStarted 2021-09-09

Plain-language summary

This is an exploratory research study with the aim of identifying specific cancer biomarkers in various subtypes of prostate cancer. Blood samples will be collected from 60 participants divided into 40 patients and 20 healthy donors.

Who can participate

Age range

18 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participant is willing and able to give and sign a written informed consent for participation in the study * Male, aged 18 years or above * Diagnosed with prostate cancer at low or high risk * Candidate to active surveillance (in case of low-risk disease) or treatment with curative intent such as radical prostatectomy or radiation therapy (in case of low risk patients not willing to undergo active surveillance or patients with high risk disease) * Healthy participants undergoing a visit at the site for reason other than cancer diagnosis (including prostate cancer) Exclusion Criteria: * History of other malignancies other than prostate cancer (for healthy participants includes also prostate cancer) * Undergone surgery or treatment for prostate cancer before enrolment * Presence of known severe coagulation or haematological disorder * Absence of written signed informed consent for participation in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of commercial Antibodies capable of identify specific Prostate Cancer Biomarkers

Timeframe: day 1 : blood collection day

Trial details

NCT IDNCT04964271

SponsorTethis S.p.A.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Prostatic Neoplasms trials